Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)

PHASE1UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

November 30, 2020

Conditions
Malaria
Interventions
BIOLOGICAL

Plasmodium falciparum sporozoite (PfSPZ)

Plasmodium falciparum sporozoites

Trial Locations (2)

80108

RECRUITING

KEMRI Wellcome Trust Research Programme, Kilifi

Unknown

NOT_YET_RECRUITING

KEMRI Centre for Clinical Research, Nairobi

Sponsors
All Listed Sponsors
collaborator

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

collaborator

Sanaria Inc.

INDUSTRY

collaborator

KEMRI Centre for Clinical Research

UNKNOWN

collaborator

Pwani University

UNKNOWN

collaborator

University of Cambridge

OTHER

collaborator

Wellcome Sanger Institute

OTHER

lead

University of Oxford

OTHER